Frontlight ResearchEarly access
Prostate cancer trials in Belgium
41 of 48 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 3Not yet taking people in BelgiumA clinical trial to learn more about the effects of AAA817 given with an androgen receptor pathway inhibitor (ARPI) in men with prostate cancer
- Where
- Edegem, Kortrijk
- Age
- 18 years and over
- People
- 265 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2024-512340-32-01 - Phase 1Taking peopleA Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
- Where
- Gent
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06788509 · EU 2024-515457-21-00 - Phase 3Taking peopleA Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
- Where
- Antwerp, Brugge, Gent, Kortrijk, La Louvière, Liège, Ottignies-Louvain-la-Neuve, Sint-Lambrechts-Woluwe
- Age
- 18 years and over
- People
- 1,203 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07164443 · EU 2025-520927-26-00 - Phase 3Taking peopleA Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
- Where
- Aalst, Antwerp, Gent, La Louvière, Liège
- Age
- 18 years and over
- People
- 800 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07225946 · EU 2025-522713-29-00 - Phase 1/2Taking peopleEIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
- Where
- Brussels
- Age
- 18 years and over
- People
- 160 worldwide
- Run by
- Eikon Therapeutics
See details and how to joinNCT07262619 · EU 2026-525248-13-00 - Phase 2Taking peopleA Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Where
- Brussels, Edegem, Ghent, Jette, Leuven
- Age
- 18 years and over
- People
- 740 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00 - Phase 3Taking peopleAn Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
- Where
- Aalst, Antwerp, Gent
- Age
- 18 years to 100 years
- People
- 450 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT05939414 · EU 2022-502956-29-00 - Phase 3Taking peopleA Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- Where
- Brussels, Ghent, Kortrijk, Leuven, Yvoir
- Age
- 18 years and over
- People
- 750 worldwide
- Run by
- Amgen
See details and how to joinNCT07213674 - Phase 3Not yet taking people in BelgiumAZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Where
- Ghent, Leuven, Liège
- Age
- 18 years and over
- People
- 670 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07611110 - Phase 3Not yet taking people in BelgiumA Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
- Where
- Brugge, Gent, Liège, Sint-Lambrechts-Woluwe
- Age
- 18 years and over
- People
- 736 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT07365995 · EU 2025-524445-27-00 - Phase 3Taking peopleA Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- Where
- Antwerp, Jette, Kortrijk, Libramont-Chevigny, Roeselare, Sint-Lambrechts-Woluwe
- Age
- 18 years and over
- People
- 700 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06952803 · EU 2024-513586-39-00 - Phase 3Active, not recruitingThis Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- Where
- Aalst, Anderlecht, Antwerp, Gent, Hasselt, Kortrijk, Leuven
- Age
- 18 years and over
- People
- 1,000 worldwide
- Run by
- Pfizer
See details and how to joinNCT07028853 · EU 2024-519369-24-00 - Phase 1Taking peopleStudy of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Where
- Kortrijk
- Age
- 18 years and over
- People
- 1,394 worldwide
- Run by
- Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00 - Phase 3Taking peoplePhase 3 Study of Xaluritamig Plus Abiraterone vs Investigator's Choice in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- Where
- Gent, Kortrijk, Leuven, Sint-Lambrechts-Woluwe, Yvoir
- Age
- 18 years and over
- People
- 297 worldwide
- Run by
- Amgen Inc.
See details and how to join2025-520555-89-00 - Phase 1/2Not yet taking people in BelgiumA Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer
- Where
- Gent
- Age
- 18 years and over
- People
- 52 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07192614 · EU 2025-520626-37-00 - Phase 3Not yet taking people in BelgiumBest Salvage Treatment for High-risk Relapsing Prostate Cancer (PEACE-9 - ESCALATE-RT)
- Where
- Aalst, Antwerp, Bruges, Brussels, Hasselt, Kortrijk, Mechelen
- Age
- 18 years and over
- People
- 140 worldwide
- Run by
- Ente Ospedaliero Cantonale, Bellinzona
See details and how to joinNCT07782112 - Phase 2/3Taking peopleTreatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers (THUNDER): A Two-part Phase 2/3 Trial
- Where
- Aalst, Anderlecht, Antwerp, Brugge, Gent, Kortrijk, La Louvière, Liège, Roeselare, Sint-Lambrechts-Woluwe, Sint-Niklaas
- Age
- 18 years and over
- People
- 493 worldwide
- Run by
- Ziekenhuis Aan De Stroom
See details and how to join2022-501551-90-00 - Phase 1Taking peopleFirst-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)
- Where
- Anderlecht, Kortrijk, Leuven
- Age
- 18 years and over
- People
- 198 worldwide
- Run by
- Bayer
See details and how to joinNCT06217822 · EU 2023-507486-26-00 - Phase 4Taking peopleLong-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
- Where
- Brussels, Gent, Roeselare
- Age
- 18 years to 100 years
- People
- 700 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT05803941 · EU 2023-503208-94-00 - Phase 2CompletedA basket study to investigate the efficacy and safety of SKB264 in combination with pembrolizumab in subjects with solid tumors
- Where
- Brasschaat, Charleroi, Sint-Lambrechts-Woluwe
- Age
- 18 years and over
- People
- 101 worldwide
- Run by
- Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd.
See details and how to joinNCT05642780 · EU 2022-502654-14-00 - No phaseNot yet taking people in BelgiumMicrowave Intervention Under Local Anesthesia
- Where
- Brussels
- Age
- 18 years and over
- People
- 20 worldwide
- Run by
- Koelis
See details and how to joinNCT07412275 - Phase 1/2Taking peopleAnti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
- Where
- Gent, Leuven, Liège, Sint-Lambrechts-Woluwe
- Age
- 18 years and over
- People
- 82 worldwide
- Run by
- Blue Earth Therapeutics Ltd
See details and how to joinNCT05413850 · EU 2024-511537-35-00 - No phaseTaking peopleSalvage Stereotactic Body Radiotherapy of the Prostate Bed for Biochemical Recurrence After Radical Prostatectomy.
- Where
- Aalst, Antwerp, Bruges, Brussels, Genk, Ghent, Hasselt, Kortrijk, La Louvière, Leuven, Mechelen, Namur, Woluwe-Saint-Lambert
- Age
- 18 years and over
- People
- 284
- Run by
- Jules Bordet Institute
See details and how to joinNCT06523634 - Phase 3Taking peopleADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)
- Where
- Charleroi, La Louvière, Namur, Ottignies-Louvain-la-Neuve
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- UNICANCER
See details and how to joinNCT04916613 · EU 2022-502425-18-00 - Phase 2/3Taking peopleTreatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers
- Where
- Aalst, Bruges, Brussels, Ghent, Kortrijk, Liège, Roeselare, Sint-Niklaas, Wilrijk
- Age
- 18 years and over
- People
- 493
- Run by
- Cancer Research Antwerp
See details and how to joinNCT06282588